Authors
Tereshhenko A. V.
Doctor of Medicine, Director, Kaluga branch of «IRTC «Eye Microsurgery» named after academician S. N. Fedorov» of the Ministry of Health of Russia, E-mail: nauka@mntk.kaluga.ru
Trifanenkova I. G.
PhD, Deputy Director for Science, «IRTC «Eye Microsurgery» named after academician S. N. Fedorov» of the Ministry of Health of Russia, E-mail: nauka@mntk.kaluga.ru
Yudina N. N.
PhD, Head, Department of vitreoretinal surgery, «IRTC «Eye Microsurgery» named after academician S. N. Fedorov» of the Ministry of Health of Russia, E-mail: nauka@mntk.kaluga.ru
Abstract
The study evaluates results of the perfluororganic compounds (PFOC) use as an immediate intraoperative tool, and as tamponade agent for vitreal cavity during surgical treatment of retinopathy of prematurity (ROP). The study group was 11 patients (17 eyes) aged 7-12 weeks (post-conceptual age 36-42 weeks) with different stages of retinopathy of prematurity. Given the high activity of the pathological process and the risk of a total retinal detachment, all patients were performed 3-port vitrectomy with the use of PFOC as immediate intraoperative tool, and as tamponade agent for vitreal cavity during surgical treatment of retinopathy of prematurity. In 9 cases when the operation was completed replacing PFOS with the air, long term outcomes in 6 cases were full retina attachment, in 3 cases minor folds of the retina persisted at the former shaft of extra retinal proliferation. In cases of short-term tamponade PFOC 5 eyes demonstrated full retina attachment, ruptures were blocked, pigmented coagulates were observed, additional laser photocoagulation was not performed. In 2 cases, where PFOC tamponade lasted for 2 weeks, under the second stage of the intervention (replacement with silicone oil or gas-air mixture) negative manifestations were identified in the form of PFOC in the vitreal cavity. Based on the results of the study it can be concluded that the use of PFOC as an intraoperative guide in surgical treatment of severe progressive forms of PH is an effective method which greatly facilitates the key stages of intervention, enhances safety and assists in stabilization of the pathological process, helping to achieve the proper anatomical proportions of the eyeball. Short-term tamponade with PFOC is advisable in cases of retinal ruptures, contributing to their effective blocking by laser photocoagulation and provides attachment of the retina without the use of silicone oil tamponade. A longer stay of PFOC in vitreal cavity is impractical due to intensification of the inflammation and ineffectiveness of vitreal intervention.
Key words
retinopathy of prematurity, vitreous surgery, perfluororganic compounds (PFOC)
References
1. Baranov A.V., Troyanovskij R.L, “Surgical treatment of late-stage retinopathy of prematurity - the last chance to see. Analysis of anatomical results.” Vestnik oftalmologii 4 (2012): 12-25.
2. Tereshchenko A.V., Belyj Yu.A, “Air vitrectomy in the surgical treatment of retinopathy of prematurity.” Oftalmohirurgiya 3 (2015): 32-36.
3. Tereshchenko A.V., Belyj YU.A., Panamareva S.V, “Tactics of retinal detachment surgery in case of progression of retinopathy of prematurity after laser treatment.” Byulleten SO RAMN 1 (2015): 28-32.
4. Tereshchenko A.V., Belyj Yu.A., Trifanenkova I.G. et al. “Early vitreoretinal surgery of rear aggressive retinopathy of prematurity.” Oftalmohirurgiya 1 (2007): 42-46.
5. Azuma N., Ito M., Yokoi T. et al. “Visual outcomes after early vitreous surgery for aggressive posterior retinopathy of prematurity.” JAMA Ophthalmol. 10 (2013): 1309-13.
6. Bottoni F., Bailo G., Arpa P. et al. “Management of giant retinal tears using perfluorodecalin as a postoperative short-term vitreoretinal tamponade: a long-term follow-up study.” Ophthalmic Surg. 6 (1994): 365-73.
7. Chang S., Ozmert E., Zimmerman N. “Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy.” American Journal of Ophthalmology 6 (1988): 668-74.
8. Cohen Y., Dubois L., Elmaleh C. “Retinal hole as a complication of long-standing subretinal perfluorocarbon liquid.” Retina 7 (2006): 843-44.
9. Devenyi R. “Perfluorocarbon liquid as a surgical adjunct in the surgical repair of stage V retinopathy of prematurity.” Br J Ophthalmol. 4 (1993): 258.
10. Devenyi R. “The use of perfluorocarbon liquid in the surgical repair of stage 5 retinopathy of prematurity.” Can J Ophthalmol. 6 (1993): P. 294-95.
11. Haidt S., Clark L., Ginsberg J. “Liquid perfluorocarbon replacement in the eye.” Investigative Ophthalmology & Visual Science 1982. Vol. 22. Article. 233.
12. Imaizumi A., Kusaka S., Noguchi H. et al. “Efficacy of short-term postoperative perfluoro-n-octane tamponade for pediatric complex retinal detachment.” Am J Ophthalmol. 2 (2014): 384-89.
13. Joussen A., Wong D. “The concept of heavy tamponades – chances and limitations.” Graefe’s Archive for Clinical and Experimental Ophthalmology. 9 (2008): 1217-24.
14. Kychenthal A., Dorta P. “25-gauge lens-sparing vitrectomy for stage 4A retinopathy of prematurity.” Retina 3 (2008): 65-8.
15. Lambrou F., Burke J., Aaberg T. “Effect of silicone oil on experimental traction retinal detachment.” Arch Ophthalmol. 9 (1987): 1269-72.
16. Micelli Ferrari T., Furino C., Lorusso V. et al. “Three-port lens-sparing vitrectomy for aggressive posterior retinopathy of prematurity: early surgery before tractional retinal detachment appearance.” Eur J Ophthalmol. 5 (2007): 785-89.
17. Millsap C., Peyman G., Ma P., Greve M. “The surgical management of retinopathy of prematurity using a perfluorocarbon liquid.” Int Ophthalmol. 2 (1994): 97-100.
18. Nishina S., Yokoi T., Yokoi T. et al. “Effect of early vitreous surgery for aggressive posterior retinopathy of prematurity detected by fundus fluorescein angiography.” Ophthalmology. 12 (2009): 2442-7.
19. Sakurai E., Ogura Y. “Removal of residual subfoveal perfluoro-n-octane liquid.” Graefe’s Archive for Clinical and Experimental Ophthalmology 7 (2007): 1063-64.
20. Singh R., Reddy D., Barkmeier A. et al. “Long-term visual outcomes following lens-sparing vitrectomy for retinopathy of prematurity.” Br J Ophthalmol. 11 (2012): 1395-8.
21. Sirimaharaj M., Balachandran C., Chan W. et al. “Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears.” Br J Ophthalmol. 9 (2005): 1176-79.
22. Sparrow J., Ortiz R., MacLeish P., Chang S. “Fibroblast behavior at aqueous interfaces with perfluorocarbon, silicone, and fluorosilicone liquids.” Invest Ophthalmol Vis Sci. 4 (1990): 638-46.
23. Tereschenko A.V., Belyi I.A., Sidorova Yu.A., Trifanenkova I.G. “Early Vitrectomy for Aggressive Posterior Retinopathy of Prematurity.” Opthalmic Res. 1 (2015): 46.
24. Yu Q., Liu K., Su L. et al. “Perfluorocarbon liquid: its application in vitreoretinal surgery and related ocular inflammation.” Biomed Res Int. 2014. Article ID 250323. 6 p.
25. Zimmerman N., Faris D. “The use of N-perfluorocarbon amines in complicated retinal detachments.” Investigative Ophthalmology & Visual Science. 1984. Vol. 25. Article. 258.